Similarly, increased metastasis and poor prognosis were correlated with RRM2B overexpression in head and neck cancer (Yanamoto et al., 2003), esophageal cancer (Okumura et al., 2006) and lung sarcomatoid carcinoma (Chen et al., 2017). This evidence concerns the gene RRM2B and head and neck cancer.